Hettema Anita, Shongwe Siphesihle, Sisel Haley, Khumalo Mxolisi, Gama Ncediso, Khanyile Nolwazi, Mahlalela Buyile, Matse Sindy Nana, Peterson Jill M
FHI 360, Mbabane, Eswatini.
FHI 360, Durham, North Carolina, USA.
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26490. doi: 10.1002/jia2.26490.
Eswatini prepared for the national rollout of HIV pre-exposure prophylaxis (PrEP) choice through a mixed-method demonstration study introducing the PrEP dapivirine vaginal ring in 12 Ministry of Health-supported sites. The Eswatini PrEP Ring Study aimed to describe user preferences for, and experiences with, the PrEP ring, and provider impressions. The objective was to provide real-world data on client preferences and experiences related to PrEP choice, and healthcare provider perspectives on the feasibility and acceptability of offering PrEP choice. A subset of quantitative findings is presented here.
During May 2023-August 2024, 12 study sites in Eswatini began offering a choice between the PrEP ring and oral PrEP to women 18 years and older who were HIV negative, not pregnant or breastfeeding, and interested in PrEP. Current oral PrEP users who were satisfied with the method were not recruited. Users' early experiences with the PrEP ring were assessed through structured enrolment and follow-up questionnaires. Factors associated with choosing the PrEP ring at enrolment were assessed using logistic regression. During the first 2 months of offering PrEP choice, providers (n = 16) completed a structured questionnaire on the feasibility and acceptability of PrEP choice service delivery.
NCT05889533 RESULTS: At enrolment, 69% (n = 625/904) chose the PrEP ring. Predictors for choosing the ring included ages 25+ (25-34 years AOR = 1.44, 95% CI [1.03, 2.02]; ages 35+ years AOR = 1.69, 95% CI [1.07, 2.68]), higher education (AOR = 1.71 for some/completed high school, 95% CI [1.20, 2.43]; AOR = 1.87 for vocational/tertiary education, 95% CI [1.21, 2.90]) and using either longer-acting (AOR = 2.23, 95% CI [1.28, 3.89]) or shorter-acting contraceptives (AOR = 1.63, 95% CI [1.14, 2.32]) versus no modern family planning method. Participants reported high levels of ease and confidence (98%) in using the ring. Ninety-four percent of PrEP counsellors (n = 8) and nurses (n = 8) felt prepared to offer PrEP choice and liked choice counselling but had concerns about clients' ability to return on time for refills of either method.
Many women in Eswatini were willing to try the PrEP ring. Providers were enthusiastic about counselling on PrEP choice and introducing women to the ring.
斯威士兰通过一项混合方法示范研究为全国推广艾滋病毒暴露前预防(PrEP)选择做准备,该研究在卫生部支持的12个地点引入了达匹韦林阴道环用于PrEP。斯威士兰PrEP环研究旨在描述用户对PrEP环的偏好和体验以及提供者的印象。目的是提供关于与PrEP选择相关的客户偏好和体验的真实世界数据,以及医疗保健提供者对提供PrEP选择可行性和可接受性的看法。此处展示了一部分定量研究结果。
在2023年5月至2024年8月期间,斯威士兰的12个研究地点开始为18岁及以上、艾滋病毒阴性、未怀孕或未哺乳且对PrEP感兴趣的女性提供PrEP环和口服PrEP之间的选择。对当前口服PrEP方法满意的使用者未被招募。通过结构化的入组和随访问卷评估使用者对PrEP环的早期体验。使用逻辑回归评估入组时选择PrEP环的相关因素。在提供PrEP选择的前两个月,提供者(n = 16)完成了一份关于PrEP选择服务提供可行性和可接受性的结构化问卷。
NCT05889533 结果:入组时,69%(n = 625/904)选择了PrEP环。选择环的预测因素包括25岁及以上(25 - 34岁,调整后比值比[AOR] = 1.44,95%置信区间[CI][1.03, 2.02];35岁及以上,AOR = 1.69,95% CI[1.07, 2.68])、高等教育程度(高中部分/完成,AOR = 1.71,95% CI[1.20, 2.43];职业/高等教育,AOR = 1.87,95% CI[1.21, 2.90])以及使用长效(AOR = 2.23,95% CI[1.28, 3.89])或短效避孕药(AOR = 1.63,95% CI[1.14, 2.32])与未使用现代计划生育方法相比。参与者报告使用环时的轻松程度和信心水平较高(98%)。94%的PrEP咨询师(n = 8)和护士(n = 8)认为自己准备好提供PrEP选择并喜欢选择咨询,但担心客户能否按时回来补充任何一种方法。
斯威士兰的许多女性愿意尝试PrEP环。提供者热衷于就PrEP选择进行咨询并向女性介绍该环。